Innovation Pharmaceuticals Inc.
IPIX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$880 | -$681 | -$698 | -$361 |
| Dep. & Amort. | $94 | $93 | $93 | $94 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $4 | $4 | $21 |
| Change in WC | $42 | $126 | $94 | -$245 |
| Other Non-Cash | $64 | $89 | $38 | $14 |
| Operating Cash Flow | -$677 | -$369 | -$469 | -$477 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$12 | -$17 | -$27 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$2 | -$12 | -$17 | -$27 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $25 | -$25 | $0 | -$9 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $3 | $0 |
| Financing Cash Flow | $25 | -$41 | $3 | -$41 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$654 | -$422 | -$483 | -$545 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,518 | $1,940 | $2,423 | $2,968 |
| End Cash | $864 | $1,518 | $1,940 | $2,423 |
| Free Cash Flow | -$679 | -$381 | -$486 | -$504 |